Name | Number of supported studies | Average coverage | |
---|---|---|---|
T cell | 7 studies | 25% ± 6% | |
natural killer cell | 6 studies | 32% ± 14% | |
CD8-positive, alpha-beta T cell | 6 studies | 31% ± 11% | |
plasmablast | 5 studies | 31% ± 13% | |
erythroblast | 5 studies | 37% ± 16% | |
pro-B cell | 5 studies | 29% ± 7% | |
CD4-positive, alpha-beta T cell | 5 studies | 31% ± 10% | |
B cell | 4 studies | 24% ± 6% | |
hematopoietic precursor cell | 4 studies | 32% ± 17% | |
epithelial cell | 4 studies | 28% ± 11% | |
endothelial cell | 4 studies | 23% ± 6% | |
effector CD8-positive, alpha-beta T cell | 4 studies | 28% ± 11% | |
neural crest cell | 3 studies | 23% ± 5% | |
abnormal cell | 3 studies | 19% ± 2% | |
granulocyte monocyte progenitor cell | 3 studies | 34% ± 19% | |
transit amplifying cell | 3 studies | 37% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 32% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3757.98 | 1445 / 1445 | 100% | 133.09 | 183 / 183 |
breast | 100% | 3740.79 | 459 / 459 | 100% | 141.35 | 1116 / 1118 |
skin | 100% | 3987.67 | 1809 / 1809 | 100% | 183.38 | 471 / 472 |
stomach | 100% | 2821.47 | 359 / 359 | 100% | 134.42 | 285 / 286 |
bladder | 100% | 4059.00 | 21 / 21 | 100% | 156.24 | 502 / 504 |
lung | 100% | 3257.25 | 578 / 578 | 100% | 117.69 | 1150 / 1155 |
uterus | 100% | 4504.14 | 170 / 170 | 100% | 225.05 | 457 / 459 |
intestine | 100% | 3788.52 | 966 / 966 | 99% | 150.75 | 523 / 527 |
thymus | 100% | 2805.34 | 653 / 653 | 99% | 87.45 | 598 / 605 |
ovary | 100% | 3520.95 | 180 / 180 | 98% | 98.18 | 422 / 430 |
brain | 99% | 1463.67 | 2607 / 2642 | 98% | 70.86 | 693 / 705 |
prostate | 100% | 2813.91 | 245 / 245 | 96% | 52.86 | 483 / 502 |
pancreas | 97% | 1410.03 | 319 / 328 | 99% | 80.50 | 176 / 178 |
kidney | 100% | 2415.94 | 89 / 89 | 90% | 58.59 | 814 / 901 |
adrenal gland | 100% | 2272.36 | 258 / 258 | 86% | 50.48 | 197 / 230 |
liver | 96% | 1313.48 | 218 / 226 | 80% | 64.35 | 324 / 406 |
adipose | 100% | 3423.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3293.06 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 231.41 | 29 / 29 |
spleen | 100% | 4544.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 231.24 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.95 | 1 / 1 |
heart | 99% | 2087.87 | 853 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 1296.03 | 789 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 92.66 | 78 / 80 |
peripheral blood | 85% | 4453.81 | 786 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006268 | Biological process | DNA unwinding involved in DNA replication |
GO_0000727 | Biological process | double-strand break repair via break-induced replication |
GO_0006270 | Biological process | DNA replication initiation |
GO_0030174 | Biological process | regulation of DNA-templated DNA replication initiation |
GO_0006271 | Biological process | DNA strand elongation involved in DNA replication |
GO_1902975 | Biological process | mitotic DNA replication initiation |
GO_0005730 | Cellular component | nucleolus |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005813 | Cellular component | centrosome |
GO_0005658 | Cellular component | alpha DNA polymerase:primase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0042555 | Cellular component | MCM complex |
GO_0071162 | Cellular component | CMG complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0017116 | Molecular function | single-stranded DNA helicase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | MCM3 |
Protein name | Minichromosome maintenance complex component 3 DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102) DNA replication licensing factor MCM3 (EC 3.6.4.12) |
Synonyms | |
Description | FUNCTION: Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built . The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity . Required for the entry in S phase and for cell division (Probable). . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . |
Accessions | ENST00000419835.8 A0A499FHX9 ENST00000229854.12 A0A0S2Z492 Q7Z6P5 P25205 ENST00000421471.1 A0A0S2Z4T1 J3KQ69 ENST00000616552.4 [P25205-2] ENST00000596288.7 [P25205-1] |